Kimia Biosciences Ltd
₹33.56
+0.84 (2.57%)
Thu, 22 Oct 2026, 06:54 pm
Kimia Biosciences News
Kimia Biosciences AGM approves borrowing limits
Kimia Biosciences held its 33rd AGM, approving special resolutions to increase borrowing limits and create charges on assets. The meeting also ratified director appointments.
28 Sept 2026
companies
Kimia Biosciences closes trading window for Q2FY27 results
Kimia Biosciences Ltd will close its trading window from October 1, 2026, until 48 hours after declaring Q2FY27 financial results, restricting insider trading.
26 Sept 2026
companies
Kimia Biosciences FY26 net profit falls 22.7%
Kimia Biosciences reported a 22.7% decline in net profit to ₹743.37 lakh for FY26. Revenue from operations decreased to ₹11,488.38 lakh.
29 May 2026
companies
Kimia Biosciences Board Meet on May 29
Kimia Biosciences Limited board meets on May 29, 2026, to consider audited financial results for FY26. Trading window remains closed until results declaration.
20 May 2026
companies
Kimia Biosciences Files Q4 FY26 SEBI Compliance Certificate
Kimia Biosciences Limited submitted its quarterly compliance certificate under SEBI Regulation 74(5) for the quarter ended March 31, 2026, confirming adherence to dematerialization norms.
15 Apr 2026
companies
Market Current News
Khazanchi Jewellers Limited
Khazanchi Jewellers gets in-principle approval for main board migration
Khazanchi Jewellers Limited received in-principle approval from BSE and NSE to migrate from the SME platform to the Main Board. The approvals are valid for 45 days.
21 Oct 2026
ipo
Core4 Engineers SME IPO: ₹285 Cr Order Book
Core4 Engineers Limited files DRHP for SME IPO. The Mysore-based EPCC firm reports ₹91.34 Cr FY26 revenue and a ₹285.83 Cr order book, seeking funds for working capital.
21 Oct 2026
ipo
SFC Env Tech IPO: ₹150 Cr Fresh Issue
SFC Environmental Technologies files DRHP for a ₹150 crore fresh issue. The Navi Mumbai-based firm holds 80% market share in SBR technology with FY26 revenue at ₹803.63 crore.
21 Oct 2026
ipo
EAAA India Alternatives IPO: ₹1,200 Cr OFS
EAAA India Alternatives files DRHP for a ₹1,200 crore Offer for Sale. No fresh issue; proceeds go to promoters. AUM stands at ₹953,448.78 million.
21 Oct 2026
ipo
Paras Healthcare IPO Day 1: Demand Sluggish at 0.08x
Paras Healthcare IPO saw weak response on Day 1 with overall subscription at 0.08x. Retail led demand at 0.41x, while QIB interest remained nil.
21 Oct 2026
ipo